Compound: Afatinib

Drug Target: ERBB2, EGFR

Drug Target pathway: EGFR signaling


Associations from all tissue specific and pan-cancer ANOVA analyses overlaid. Hover the pointer over each circle to reveal the context-specific details of an association.

Retrieving drug sensitivity data...

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.